Results 1 to 10 of about 8,461 (117)
Dupilumab as a treatment for bullous pemphigoid in a liver transplant recipient: A case report [PDF]
SAGE Open Medical Case ReportsBullous pemphigoid is a common subepidermal autoimmune bullous disease that affects the skin and mucous membranes. It is more prevalent in the elderly, often resulting in significant morbidity and mortality.
Sarah S. Rashid +2 more
doaj +2 more sources
Dyshidrosiform Bullous Pemphigoid
Medicina, 2021 Dyshidrosiform bullous pemphigoid is a variant of bullous pemphigoid. At least 84 patients with dyshidrosiform bullous pemphigoid have been described. Dyshidrosiform bullous pemphigoid usually presents with pruritic blisters in elderly individuals; the ...
Philip R. Cohen
doaj +1 more source
Prevalence, Spectrum and Clinical Implications of Malignancies in Patients with Bullous Pemphigoid
Acta Dermato-Venereologica, 2023 Current research on the malignancy rate and spectrum of malignancies in patients with bullous pemphigoid is contradictory. The aims of this study were to determine the prevalence and spectrum of malignancy in patients with bullous pemphigoid and to ...
Sharon Baum +4 more
doaj +1 more source
Case Reports in Dermatology, 2022 Bullous pemphigoid is the most common acquired bullous disease with an autoimmune basis and a tendency to involve mostly old people. By rising incidence of diabetes all over the world, consumption of antidiabetes medications has also increased.
Kamran Balighi +4 more
doaj +1 more source
Immunomodulator Galectin-9 is Increased in Blood and Skin of Patients with Bullous Pemphigoid
Acta Dermato-Venereologica, 2021 Massive recruitment of eosinophils into the dermis is a hallmark of bullous pemphigoid pathogenesis. Identifying the chemoattractant(s) guiding eosinophils into the skin in bullous pemphigoid is a prerequisite to therapeutic targeting of eosinophil ...
Jasper Pruessmann +8 more
doaj +1 more source
Comorbidity in bullous pemphigoid: up-date and clinical implications
Frontiers in Immunology, 2023 Bullous pemphigoid is the most common autoimmune blistering disease in industrialized countries and particularly affects the elderly. In this patient population, comorbid diseases are frequent and may complicate management and treatment of bullous ...
Johanna Huttelmaier +2 more
doaj +1 more source
BMC Endocrine Disorders, 2021 Background Bullous pemphigoid is the most common bullous chronic autoimmune skin disease. Recent studies have suggested dipeptidyl-peptidase 4 inhibitors as possible predisposing agents of bullous pemphigoid.
Vaia Lambadiari +10 more
doaj +1 more source
Risk of Serious Infections in Patients with Bullous Pemphigoid: A Population-based Cohort Study
Acta Dermato-Venereologica, 2023 Patients with bullous pemphigoid are susceptible to serious infections, which are the leading cause of death in these patients. The aims of this population-based cohort study were to investigate the incidence and spectrum of serious infections in ...
Tsung-Hsien Chang +4 more
doaj +1 more source
Bilateral localized bullous pemphigoid in a young adult patient: A case report
SAGE Open Medical Case Reports, 2023 Bullous pemphigoid is the most common autoimmune subepidermal blistering disease, which typically presents in the elderly. Localized bullous pemphigoid is a rare variant of bullous pemphigoid, with only about 100 cases reported up to date. In this report,
Pedram Nourmohammadpour +5 more
doaj +1 more source
SAGE Open Medical Case Reports, 2023 Bullous pemphigoid is an acquired autoimmune subepidermal blistering disease that can arise following exposure to systemic medication, referred to as drug-induced bullous pemphigoid.
Louise M Gresham, Mark G Kirchhof
doaj +1 more source